Loading clinical trials...
Loading clinical trials...
To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Stanford University
NCT06008808 · Graft Vs Host Disease, Graft-versus-host-disease, and more
NCT00106925 · Graft-versus-leukemia, Graft vs Host Disease, and more
NCT06450925 · Graft Vs Host Disease, Vitamin A Deficiency, and more
NCT04337515 · Graft Vs Host Disease, Graft-versus-host-disease
NCT06681922 · Graft Vs Host Disease
Stanford University Cancer Center
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions